Relapsed/refractory acute myeloid leukemia (AML), a so-called blood most cancers, has a particularly poor prognosis due to resistance to anti-cancer medicine and frailty...
Video content material above is prompted by the next questions:How would you describe your present medical method for high-risk sufferers with CLL/SLL, together...